Abstract: One or more embodiments are directed to a microfluidic delivery system that dispenses a fluid in a direction that, at least in part, opposes gravity. In one embodiment, the microfluidic delivery system includes a microfluidic refill cartridge that is configured to be placed in a housing. The microfluidic refill cartridge includes at least one nozzle that faces upward or off to a side. The microfluidic refill cartridge includes a fluid transport member that allows fluid to travel upward from a fluid reservoir in opposition to gravity. A fluid path is located above the fluid transport member placing an end of the fluid transport member in fluid communication with a chamber and a nozzle. In response to the microfluidic delivery system receiving an electrical signal, an ejection element is configured to cause fluid in the chamber to be expelled through the nozzle.

Abstract: A system for disinfecting a fluid, including: a flow cell including one or more inlet ports and one or more outlet ports, wherein the flow cell is configured to communicate a fluid containing a biological contaminant from the one or more inlet ports to the one or more outlet portions through an interior portion thereof; and one or more point radiation sources disposed about the flow cell, wherein the one or more point radiation sources are operable for delivering radiation to the biological contaminant; wherein an interior surface of the flow cell is operable for reflecting the radiation delivered to the biological contaminant by the one or more point radiation sources; and wherein the interior surface of the flow cell is operable for reflecting the radiation delivered to the biological contaminant by the one or more point radiation sources such that a radiation intensity is uniform throughout the interior portion of the flow cell. In one exemplary embodiment, the flow cell is an integrating sphere.

Abstract: Disclosed is a method for preparing an oxidized cellulose hemostatic product, including using a sodium hydroxide solution with the concentration of 1 to 5% to pre-process a cellulose product; after removing lignins or impurities on the fiber surface, using an alkaline solution to activate the fiber surface further; after the activating treatment, using demin-water for washing until it is neutral and drying the obtained cellulose product in air to obtain a raw material; using a sodium hydroxide solution with the concentration of 5 to 20% as a solvent; adding the cellulose product, carbamide and ZnO that are 3 to 10%, 2% and 2% of the sodium hydroxide solution respectively.

Abstract: The present disclosure provides amine-modified polymer foams, which may be used for wound dressing materials. For example, the modified materials can include a covalently attached molecule comprising free amine groups. Such amine groups can be used, for instance, to conjugate biologically active polypeptides and/or linkers. Methods for using modified polymers are also provided.

Abstract: Disclosed herein are improved surgical techniques for repairing bone defects in a sternum during a sternotomy procedure and implants adapted for such techniques. In an exemplary embodiment, provided is a fusion strip made of an osteoconductive material and of a dimension that is especially adapted for improved repair of sternal bone defects.

Abstract: A multilayer protein film has a mass of greater than 0.5 ?g/cm2 and consists essentially of protein. A drug delivery device comprises the multilayer protein film onto which a pharmaceutically active agent can be loaded. A biomedical implant comprises an implant substrate and the multilayer protein film on at least a portion of the implant substrate surface. A method of making a multilayer protein film having a mass of greater than 0.5 ?g/cm2 comprises contacting a substrate with a protein solution at a temperature of from about 30° C. to about 95° C, wherein a multilayer protein film having a mass of greater than 0.5 ?g/cm2 is formed on the substrate.

Abstract: A method for coupling a body conduit to tissue is provided. The method includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

Abstract: Embodiments of the invention include drug delivery coatings and devices including the same. In an embodiment, the invention includes a drug delivery coating including a polymeric layer. The polymeric layer can include a hydrophilic outer surface. The coating can also include a matrix contacting the hydrophilic outer surface. The matrix can include a particulate hydrophobic therapeutic agent and a cationic agent. The polymeric layer can further include a hydrophilic polymer having pendent photoreactive groups and a photo-crosslinker including two aryl ketone functionalities. Other embodiments are also included herein.

Abstract: A system for drawing blood from a heart of a patient, includes a blood pump, an outflow cannula and a flexible cannula assembly. The cannula assembly further includes a flexible cannula body including a proximal end, a distal end, an inner wall defining a lumen, and an outer wall. A tip is coupled with the distal end of the cannula body, and an anchor is coupled to the tip. The anchor is configured to engage an internal structure of the heart and resists movement of the cannula assembly in at least one direction along the flexible cannula body. A ring member is configured to be coupled to the heart wall and is positioned at least partially around the outer wall of the cannula body proximally relative to the tip. The ring member is further configured to provide hemostasis between the heart wall and the cannula body.

Abstract: A blood pump system includes two blood pumps, which may be implanted into a patient. The blood pumps may comprise VAD pumps. Control devices and methods operate the pumps such that they can function as a total artificial heart.

Abstract: A blood pump with an integrated flow sensor is provided. The blood pump may include an implantable pump for pumping blood having a housing, a flow path extending within the housing and at least one movable element within the housing for impelling blood along the flow path and a sensor for measuring the flow rate of blood through the pump. According to one embodiment, the sensor may be mounted to the housing of the pump. In accordance with a further embodiment, the housing may have an exterior surface defining a cavity, and the sensor may be located within the cavity.

Abstract: Endoluminal devices are provided for the treatment of heart failure which include a central body adapted to permit the passage of interatrial blood, at least one anchor attached to the central body adapted to keep the endoluminal device in position within a defect present in the atrial septum of a patient's heart, and at least one control element engaged with the central body in a rotating manner. The rotation of the control element in relation to the central body creates a two-way flow of interatrial blood which allows the reduction of high pressure in the right side and in the left side of the heart.

Abstract: A medical treatment system, such as peritoneal dialysis system, may include control and other features to enhance patient comfort and ease of use. A fluid trap of a peritoneal dialysis cycler may have a valved connection to a vacuum source or a positive pressure source. The fluid trap can be connected to the vacuum source in order to sealingly engage a flexible membrane of a pumping cassette to a control surface of the cycler during a therapy. Any fluid entering a space between the membrane and control surface can be drawn away and collected in the fluid trap. The fluid trap alternatively can be connected to a positive pressure source in order to aid in separating the membrane from the control surface to facilitate removal of the pumping cassette from the cycler. The fluid trap may include a liquid detection sensor.

Abstract: An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals. Other features and embodiments are disclosed.

Abstract: The bifurcated peritoneal catheter serves as a peritoneal dialysis device for patients with kidney failure. The catheter includes a primary tube with two porous internal tubes extending therefrom at a small acute angle to one another. The two internal tubes provide a solution to the potential problem of blockage in a single catheter tube, greatly reducing the potential need for surgery to remove and replace such a single catheter tube. The bifurcated peritoneal catheter includes a subcutaneous cuff, and can include a second deep cuff in the abdominal wall. Either or both of the internal tubes can be straight, curved or coiled, with the curvatures and coils oriented in the same direction, toward one another, or away from one another.

Abstract: Embodiments of the invention relate to an extracorporeal perfusion apparatus comprising an extracorporeal blood circuit for conveying blood, a filtrate circuit for conveying blood plasma, and a controller, wherein the filtrate circuit is connected to the extracorporeal blood circuit by means of a filter, wherein the filter has a sieving coefficient of 5% for substances having a molar mass of 340,000 g/mol (relative molecular mass of 340 kDa), and wherein a depletion agent comprising a first carrier having a neutral, hydrophobic surface is arranged in the filtrate circuit, wherein the perfusion apparatus comprises a dispensing means for feeding an endotoxin-binding lipopeptide into the extracorporeal blood circuit, wherein the endotoxin-binding lipopeptide is selected from the group consisting of polymyxins, polymyxin derivatives, prodrugs thereof, and a combination thereof.

Abstract: Methods are provided for collecting platelet-rich plasma. A disposable flow circuit is mounted to a fluid processing device having a fluid separation chamber and an injection device. A fluid containing plasma and platelets is continuously conveyed from a fluid source into the fluid separation chamber and processed to produce platelet-rich plasma. At least a portion of the platelet-rich plasma is automatically conveyed from the fluid separation chamber into the injection device, which is directly connected to a pump device such that at least a portion of the platelet-rich plasma from the fluid separation chamber is automatically conveyed into the pump device prior to being conveyed into the injection device. The injection device with the platelet-rich plasma is then detached from the disposable flow circuit.

Abstract: A device for nasal lavage is described. The device ejects a gentle flow of fluid under pressure. The fluid stream provides a high quantity of fluid at low pressure. The low pressure fluid stream is more comfortable for a user than a high pressure fluid stream that is delivered by some types of pressurized cans of solution.

Abstract: A catheter tip is disclosed comprising a tip electrode comprising a ledge feature, and a center cavity and a manifold assembly comprising a fluid lumen manifold and a stop tube. The stop tube can be coupled to the fluid lumen manifold and configured to abut the ledge feature such that a distal end of the fluid lumen manifold extends a pre-determined distance into the center cavity of the tip electrode. The fluid lumen manifold can comprise a plurality of sideholes which can be sized and configured to distribute an irrigant to the tip electrode. The catheter tip can comprise a flexible tip electrode.

Abstract: An apparatus for accessing the lumen of a vessel. The apparatus includes a handheld device and a cartridge. The handheld device includes an imaging device attachment utilized to secure an image capturing instrument, an arm coupled to the imaging device attachment. The cartridge includes a sheath, needle or guidewire coupled to the cartridge. The sheath or needle extends to the insertion depth when fully advanced, thereby allowing the sheath, needle, or guidewire to access the lumen of a vessel.

Abstract: A combined detectional and positional sensor for a syringe pump. The sensor can comprise a syringe thumbpress clamp that is pivotable so that an engagement pin deflects a linear membrane potentiometer first circuit thus providing a closed switch for detection of a syringe in the pump and a variable signal return for indication of plunger head position. Embodiments of the sensor can be used in relatively large syringe pumps and in relatively small syringe pumps, for example.

Abstract: A tubeless fluid delivery device, comprising a controller (11) and a pump (12) combined with the controller (11). The controller (11) comprises a first housing having a first built-in circuit. The first housing is provided with a first engagement portion and a first insertion portion electrically connected to the first built-in circuit. The pump (12) comprises a second housing having a second built-in circuit, a drug storage cylinder, a piston, a push rod, a driving means and a battery. The second housing is provided with a second engagement portion correspondingly engaged with the first engagement portion and a second insertion portion electrically connected to the second built-in circuit. The second insertion portion is correspondingly inserted in the first insertion portion to realize electrical connection. The present disclosure solves the problem that a drug fluid infusion device in the prior art has complex operation, large size and high cost.

Abstract: The control device is used to control delivery of fluids from a multi-fluid delivery system during a medical injection procedure. The fluid delivery system includes an injector used to deliver injection fluids to a patient. The control device is operatively associated with the injector for controlling discrete flow rates of injection fluids delivered to the patient. The control device includes a housing, first and second actuators associated with the housing, and an electronic substrate disposed within the housing and having a conductive pattern. The first actuator is operatively associated with the conductive pattern. The conductive pattern includes a plurality of predetermined digital values corresponding to discrete flow rates of injection fluids to be delivered by the injector. The second actuator is operatively associated with the electronic substrate and initiates output signals to the injector corresponding to desired mixture ratios of the injection fluids to be delivered by the injector.

Abstract: It may be desirable to monitor or control a pump remotely. For example, the pump may be positioned near the patient, with remote control or monitoring of the pump occurring in a control room. In one exemplary embodiment, the pump is used in an MRI environment. In another exemplary embodiment, the pump is used in a hyperbaric chamber. The pump may monitor one or more physiological parameters and transmit them to the remote. The pump may also transmit information relating to the pump's operation. The pump may send the device and/or physiological data using one or more packets. The packets may consist of low priority sequential packets and high-priority asynchronous packets. The high-priority packets may enable the real-time monitoring of a patient's heart beat or other physiological parameter.

Abstract: A method, computer usable program product, or a system for managing a blood glucose level of a person including providing a device worn exterior to the person for monitoring a set of treatment factors and a set of environmental factors associated with the person, predicting a blood glucose level for the person based on the set of treatment factors and the set of environmental factors, and responsive to predicting a blood glucose level for the person dropping lower than a predetermined minimum value, supplying carbohydrates to the person.

Abstract: A system and a method for monitoring at least one blood parameter of blood of different patients, comprising a plurality of access devices for establishing at least one access to the blood of each patient through skin, a plurality of removal devices for removing a quantity of the blood from each patient in order to obtain at least one blood sample, at least one blood analysis device for analyzing the at least one blood sample with respect to predeterminable blood parameters and for generating individual blood parameter data sets, a calculation device which can be used jointly for a plurality of blood parameter data sets of the different patients for calculating data sets of drug parameters of drugs to be administered to a respective patient on the basis of the individual blood parameter data sets, and a plurality of supply devices for supplying a respective drug having the calculated data sets of the drug parameters.

Abstract: A diagnostic Electrochemical Impedance Spectroscopy (EIS) procedure is applied to measure values of impedance-related parameters for one or more sensing electrodes. The parameters may include real impedance, imaginary impedance, impedance magnitude, and/or phase angle. The measured values of the impedance-related parameters are then used in performing sensor diagnostics, calculating a highly-reliable fused sensor glucose value based on signals from a plurality of redundant sensing electrodes, calibrating sensors, detecting interferents within close proximity of one or more sensing electrodes, and testing surface area characteristics of electroplated electrodes. Advantageously, impedance-related parameters can be defined that are substantially glucose-independent over specific ranges of frequencies. An Application Specific Integrated Circuit (ASIC) enables implementation of the EIS-based diagnostics, fusion algorithms, and other processes based on measurement of EIS-based parameters.

Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The system provides the user with the ability to understand the effects of bolus insulin dosing upon their glucose levels. Specifically, the system provides a message that must include: (a) the trend of the user's glucose; (b) the recommended bolus; and (c) the actual bolus.

Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves storing alert configuration information for the user, identifying an alert condition while operating the infusion device to deliver the fluid based at least in part on the alert configuration information for the user, and in response to identifying the alert condition, providing a user notification in accordance with the user's stored alert configuration information.

Abstract: The present disclosure relates to a drug delivery device, in particular pen-type injectors, wherein a number or pre-set doses can be administered. In particular, the present disclosure relates to such drug delivery devices, where a user may activate the dose injection process and wherein the user is still able to control the dose injection process even after a dose injection process has been activated. The process of injecting a dose is supported by some kind of energy storing means as well as by a force to be exerted by a user. Moreover, the disclosure characterizes by a reduced amount of mechanical components.

Abstract: Processes and devices for delivering a fluid by chemical reaction are disclosed. A chemical reaction is initiated in a reaction chamber to produce a gas, and the gas acts upon a piston to deliver the fluid. Preferred devices typically include an upper chamber, a lower chamber, a fluid chamber, a piston between the lower chamber and the fluid chamber, and a barrier between the upper chamber and the lower chamber. When the barrier is broken, reagents in the upper chamber and the lower chamber are mixed together to generate the gas.

Abstract: A medication administering device, to which a preparation syringe containing a preparation is mounted, and which administers a preparation to a living body, and comprises a main body; a cylindrical syringe holder that is provided to the main body and into which the preparation syringe is inserted from the rear end side; a cylindrical syringe cover that supports the preparation syringe on the inner peripheral face side, and into which the preparation syringe is inserted from the distal end side; an inner case that guides the syringe cover and is removably fitted together with the syringe cover; and a distal end cap that guides the main body and is removably fitted together with the main body, and moves in conjunction with the syringe cover during attachment to the main body.

Abstract: A mixing nozzle includes at least two individual mixing channels dimensioned to create a turbulent flow effect to facilitate dispersion of the components of a medical agent, such as a liquid embolic composition, during delivery, e.g., to vasculature of a subject. In some examples, the mixing nozzle is configured to be mechanically and fluidically connected to a syringe, a catheter, or both the syringe and the catheter.

Abstract: Container holder assembly for use in a medicament delivery device, comprising a tubular body elongated in an axial direction, said tubular body having a proximal end and an opposite distal end, and a retaining member releasably arranged to said tubular body for securing an elongated container placed inside the tubular body, wherein said retaining member comprises a resilient structure capable of exerting an axial force on said container in said tubular body for holding the container in a fixed position inside the tubular body and wherein the retaining member and the tubular body respectively comprises a first and a second locking means capable of achieving a mutual mechanical connection, such that the retaining member is locked to the tubular body.

Abstract: The present invention relates to a medicament delivery device (100) having a a drive mechanism arranged to drive a plunger rod (12). A last dose limiting mechanism is arranged to interact with the drive mechanism and limit the distal end position of an actuator (3) when the plunger rod (12) has reached a pre-determined position between its distal end position and its proximal end position.

Abstract: The present invention relates to a torsion spring driven injection device for delivering multiple set doses of a liquid drug from a cartridge by moving a plunger forward inside the cartridge. The torsion spring (134) applies a rotational torque onto a drive member (120) engaging a piston rod (115) which is then driven forward by this rotation. The piston rod driver can be coupled and de-coupled from the torsion spring mechanism. In the de-coupled position, the piston rod driver is freely rotatable and can thus rotate if the piston rod is moved axially. A further torsion arrangement (124) is preferably provided such that a torque is build up between the piston rod driver and the housing whenever the piston rod is moved backwards. This torsion arrangement urges the piston rod driver to rotate in a direction bringing the piston rod forward into abutment with the plunger.

Abstract: An apparatus and methods for tracking administering of medication by syringes is provided. The apparatus may include a plunger head for a syringe. The plunger head may include a transducer that sends and receives ultrasonic signals. The plunger may also include an antenna and a microcontroller that interfaces with the transducer and the antenna. The plunger may also include a power source that powers the microcontroller and the transducer. The transducer, the antenna, the microcontroller, and the power source may be at least partially encapsulated in an elastomer housing that fits within a barrel of the syringe. The microcontroller may be programmed with instructions to calculate data representative of the quantity of medication dispensed from the barrel and transmit the data to a remote device via the antenna.

Abstract: An injection device with a dose delivering mechanism being adapted to provide a non-visual, e.g. audible and/or tactile, feedback signal when a set dose has been at least substantially injected. A first and a second part of the injection device are adapted to perform a relative rotational movement with respect to each other. The relative rotational movement causes at least two parts of the injection device to abut or engage, and this abutment or engagement causes the non-visual feedback signal to be generated. A very distinct and precise feedback is provided as compared to prior art axial solutions because the generation of the feedback signal is initiated by the relative rotational movement. Feedback signal may be generated by a change in a rotational velocity of at least one part, e.g. by changing the pitch of a threaded portion or by engaging a non-rotating part and a rotating part, thereby causing the non-rotating part to start rotating.

Abstract: A drug delivery device for dispensing a dose of a medicament includes an elongated housing extending in an axial direction, and a piston rod to operably engage with a piston of a cartridge to displace the piston in a distal axial direction. The drug delivery device further includes a drive sleeve extending in an axial direction and being rotatable against the action of a spring during a dose setting procedure and a dispensing sleeve rotatably engaged with the piston rod and being displaceable in an axial direction relative to the drive sleeve to engage with the drive sleeve in a torque transmissive way during a dose dispensing procedure.

Abstract: Apparatus is described for administering a substance to a subject. A vial contains the substance and a stopper is disposed within the vial and is slidably coupled to the vial. A first threaded element is (a) rotatable with respect to the vial and (b) substantially immobile proximally with respect to the vial during rotation of the first threaded element. A second threaded element is threadedly coupled to the first threaded element. At least a distal end of the second threaded element is substantially non-rotatable with respect to the vial, and the distal end of the second threaded element defines a coupling portion that couples the second threaded element to the stopper. The first threaded element, by rotating, linearly advances the stopper and at least the distal end of the second threaded element toward a distal end of the vial. Other embodiments are also described.

Abstract: A removal device (121, 221) for removing and disposing of a pen needle (113, 213) connectable to a drug delivery device (111, 211) includes a body (123, 223) having a cavity (141, 241) for receiving the pen needle of the drug delivery device such that a patient end (116, 216) of a needle (115, 215) of the pen needle is covered by the body. An ejector (151, 251) is movably connected to the body (123, 223) for engaging the received pen needle (113, 213) and selectively ejecting the engaged pen needle from the body. The pen needle (113, 213) is securely retained within the removal device (121, 221) without exposing the needle (115, 215) of the pen needle until the pen needle (113, 213) can be properly disposed of, such as in a sharps container, thereby substantially preventing an accidental needle stick.

Abstract: The present invention is directed to a safety needle assembly having the high safety and high operability, comprising: a hub; a cannula; a collar; a protector; and a sheath. The sheath includes an opening of housing the cannula; a cannula fixing part of locking the cannula housed in the opening; an attachment part of rotatably supporting the sheath attached to the hub or the collar; and a protrusive stopper which a user pushes by a finger to pivot the sheath thereby to house the cannula in the opening of the sheath. Herein, the stopper is arranged at a vicinity of a central portion of the sheath in a longitudinal direction at the opposite side of the aperture of the opening, or arranged at a portion closer to a distal end side than the central portion of the sheath.

Abstract: One embodiment is directed to a safety syringe system, comprising a syringe body; a plunger tip positioned within the syringe body; a needle assembly removably coupleable to the distal end of the syringe body such that a medicinal fluid may be transferred through a retractable needle coupled to a needle housing comprising the needle assembly upon insertion of the plunger tip relative to the syringe body; and a plunger control assembly coupled to the plunger tip and configured to facilitate manual insertion of the plunger tip relative to the syringe body; wherein the needle assembly comprises a needle housing member removably coupled to the retractable needle and also removably coupled to a needle cover, the needle cover providing a relatively large geometric guiding surface for aligning a proximal end of the retractable needle as it is guided into fluidic contact with the fluid reservoir of the syringe body.

Abstract: One embodiment is directed to a pre-filled safety syringe system, comprising a syringe body; a plunger tip positioned within the syringe body; a needle assembly removably coupleable to the distal end of the syringe body such that a medicinal fluid may be transferred through a retractable needle coupled to a needle housing comprising the needle assembly upon insertion of the plunger tip relative to the syringe body; and a plunger control assembly coupled to the plunger tip and configured to facilitate manual insertion of the plunger tip relative to the syringe body; wherein upon insertion and release of the plunger tip, a retraction load coupled between the syringe body and the plunger tip causes the plunger tip to be proximally withdrawn, pulling the retractable needle proximally relative to the needle housing to a safe locked and retracted state.

Abstract: Embodiments of the invention provide needle guides that facilitate direct penile injection of drug therapies.

Abstract: An injection device suitable for use with infants is disclosed. The injection device is formed from a body shield member and a cylindrical handle. The body shield member includes a concave flange at the base, which is pressed against the patient's limb and reduces local compression at the needle insertion site. The injection device also has a softer form and operates through a pressing motion. A catch member is located in the cylindrical handle, and is deployed upon fully depressing the handle. Once the handle returns to its starting position, the catch member prevents the handle from being depressed a second time and permitting the used needle to be exposed.

Abstract: Described is a medicament delivery device comprising a case, a container slidably disposed in the case between a first position and a second position, a needle coupled to the container, and a needle alignment detection mechanism disposed on the case and adapted to receive the needle. The needle alignment detection mechanism determines whether the needle is aligned with a longitudinal axis (L) when the needle is in the first position, the second position or translating between the first position and the second position.

Abstract: A syringe includes a syringe outer tube including a tubular-shaped outer tube main body configured to be filled with a liquid, a reduced diameter section located at a distal end of the outer tube main body in a projecting manner, and configured to allow the liquid to pass therethrough, the reduced diameter section having an outside diameter that is smaller than a diameter of the outer tube main body, and a ring-shaped lock adapter concentrically disposed at an outer circumferential portion of the reduced diameter section and configured to fix a mating member connected to the reduced diameter section; and a cap including a cap main body mounted on the syringe outer tube and configured to seal the reduced diameter section in a liquid-tight manner when the cap main body is in a mounted state, a ring-shaped mounting section disposed at a proximal end side of the cap main body and mounted on an outer circumferential portion of the lock adapter, and a breaking section that forms a link between the cap main body and

Abstract: A pharmaceutical injection device may comprise a main body case in the interior of which a pharmaceutical syringe can be mounted; a drive means that is provided inside the main body case and pushes out the pharmaceutical inside the pharmaceutical syringe through a syringe needle; a cover that opens and closes an opening on the side of the main body case where the syringe needle is mounted; an outside air temperature sensor that measures a first temperature, which is the temperature outside the main body case; a display component; and a controller that controls the drive means and the display component and acquires the first temperature at predetermined intervals. When the cover is closed, the controller causes the display component to display information about the storage state of the pharmaceutical in the mounted pharmaceutical syringe on the basis of the first temperature.

Abstract: A repeater system may control a pump by using a repeater and a user interface. An adhesive patch system may be used for affixing a pump or other object to a human body. Such an adhesive patch system may include two sets of adhesive members, each member including an adhesive material on at least one side so as to attach to the body. The members of the first set are spaced to allow the members of the second set to attach to the body in spaces provided between the members of the first set, and the members of the second set are spaced to allow members of the first set to detach from the body without detaching the members of the second set. Also, fill stations and base stations are provided for personal pump systems.